Allianz Life Insurance of North America’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Allianz Life Insurance of North America's BMY Position: Q3 2018 in Review
Allianz Life Insurance of North America reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q3 2018, selling an estimated $16.4K and leaving 3,621 shares worth $225K. The position accounts for 0.25% of the portfolio, ranked #105.
Allianz Life Insurance of North America first reported a position in BMY in Q1 2018 and has held it in 3 quarters since. The position peaked at $282K in Q1 2018. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.
- Allianz Life Insurance of North America held 3,621 shares of Bristol-Myers Squibb worth $225K as of Q3 2018.
- Allianz Life Insurance of North America sold 276 Bristol-Myers Squibb shares in Q3 2018, an estimated $16.4K.
- Bristol-Myers Squibb made up 0.25% of Allianz Life Insurance of North America's portfolio in Q3 2018, its #105 holding.
- Allianz Life Insurance of North America first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 3 quarters since.
- Allianz Life Insurance of North America's Bristol-Myers Squibb position peaked at $282K in Q1 2018.
- 1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.
Based on Allianz Life Insurance of North America's 13F filing for Q3 2018, filed 16 Oct 2018.